226 related articles for article (PubMed ID: 25352008)
1. Resveratrol attenuates intermittent hypoxia-induced insulin resistance in rats: involvement of Sirtuin 1 and the phosphatidylinositol-4,5-bisphosphate 3-kinase/AKT pathway.
Wang Q; Sun X; Li X; Dong X; Li P; Zhao L
Mol Med Rep; 2015 Jan; 11(1):151-8. PubMed ID: 25352008
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of long non‑coding RNA expression profiles induced by resveratrol and metformin treatment for hepatic insulin resistance.
Shu L; Hou X; Song G; Wang C; Ma H
Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34581420
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance is associated with tissue-specific regulation of HIF-1α and HIF-2α during mild chronic intermittent hypoxia.
Sacramento JF; Ribeiro MJ; Rodrigues T; Guarino MP; Diogo LN; Seiça R; Monteiro EC; Matafome P; Conde SV
Respir Physiol Neurobiol; 2016 Jul; 228():30-8. PubMed ID: 26993367
[TBL] [Abstract][Full Text] [Related]
4. A novel formula Sang-Tong-Jian improves glycometabolism and ameliorates insulin resistance by activating PI3K/AKT pathway in type 2 diabetic KKAy mice.
Kuai M; Li Y; Sun X; Ma Z; Lin C; Jing Y; Lu Y; Chen Q; Wu X; Kong X; Bian H
Biomed Pharmacother; 2016 Dec; 84():1585-1594. PubMed ID: 27829545
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol prevents chronic intermittent hypoxia-induced cardiac hypertrophy by targeting the PI3K/AKT/mTOR pathway.
Guan P; Sun ZM; Wang N; Zhou J; Luo LF; Zhao YS; Ji ES
Life Sci; 2019 Sep; 233():116748. PubMed ID: 31412263
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats.
Chi TC; Chen WP; Chi TL; Kuo TF; Lee SS; Cheng JT; Su MJ
Life Sci; 2007 Apr; 80(18):1713-20. PubMed ID: 17346750
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of the klf5-c-Myc interaction due to klf5 phosphorylation mediates resveratrol repressing the caveolin-1 transcription through the PI3K/PKD1/Akt pathway.
Yang H; Chen Q; Sun F; Zhao N; Wen L; Li L; Ran G
PLoS One; 2017; 12(12):e0189156. PubMed ID: 29211809
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol Improves Glycemic Control in Type 2 Diabetic Obese Mice by Regulating Glucose Transporter Expression in Skeletal Muscle and Liver.
Yonamine CY; Pinheiro-Machado E; Michalani ML; Alves-Wagner AB; Esteves JV; Freitas HS; Machado UF
Molecules; 2017 Jul; 22(7):. PubMed ID: 28708105
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of energy restriction and resveratrol intake on glycemic control improvement.
Milton-Laskibar I; Aguirre L; Macarulla MT; Etxeberria U; Milagro FI; Martínez JA; Contreras J; Portillo MP
Biofactors; 2017 May; 43(3):371-378. PubMed ID: 28218490
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibits hydrogen peroxide-induced apoptosis in endothelial cells via the activation of PI3K/Akt by miR-126.
Sui XQ; Xu ZM; Xie MB; Pei DA
J Atheroscler Thromb; 2014; 21(2):108-18. PubMed ID: 24107596
[TBL] [Abstract][Full Text] [Related]
11. Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats.
Gan KX; Wang C; Chen JH; Zhu CJ; Song GY
World J Gastroenterol; 2013 Mar; 19(10):1572-81. PubMed ID: 23538485
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
Graham RM; Hernandez F; Puerta N; De Angulo G; Webster KA; Vanni S
Exp Mol Med; 2016 Feb; 48(2):e210. PubMed ID: 26891914
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1.
Fröjdö S; Durand C; Molin L; Carey AL; El-Osta A; Kingwell BA; Febbraio MA; Solari F; Vidal H; Pirola L
Mol Cell Endocrinol; 2011 Mar; 335(2):166-76. PubMed ID: 21241768
[TBL] [Abstract][Full Text] [Related]
15. Vaspin as a Risk Factor of Insulin Resistance in Obstructive Sleep Apnea-Hypopnea Syndrome in an Animal Model.
Zhuang X; Ni Y; Jiang D; Pu Y; Liu X; Chen S; Sun F; Sun A; Pan Z
Clin Lab; 2015; 61(8):883-9. PubMed ID: 26427130
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities.
Liu Z; Jiang C; Zhang J; Liu B; Du Q
J Diabetes; 2016 May; 8(3):324-35. PubMed ID: 25850408
[TBL] [Abstract][Full Text] [Related]
17. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol inhibits proliferation and migration through SIRT1 mediated post‑translational modification of PI3K/AKT signaling in hepatocellular carcinoma cells.
Chai R; Fu H; Zheng Z; Liu T; Ji S; Li G
Mol Med Rep; 2017 Dec; 16(6):8037-8044. PubMed ID: 28983625
[TBL] [Abstract][Full Text] [Related]
19. Curcumin improves high glucose-induced INS-1 cell insulin resistance via activation of insulin signaling.
Song Z; Wang H; Zhu L; Han M; Gao Y; Du Y; Wen Y
Food Funct; 2015 Feb; 6(2):461-9. PubMed ID: 25474544
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium.
Penumathsa SV; Thirunavukkarasu M; Zhan L; Maulik G; Menon VP; Bagchi D; Maulik N
J Cell Mol Med; 2008 Dec; 12(6A):2350-61. PubMed ID: 18266981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
